Related Experiment Video
Updated: Jan 18, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications
Menghan Cai1, Xiaoxi Zhou1, Songna Wang1
1School of Pharmacy and Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Macau SAR 999078, China.
Insights
CD93, a protein on endothelial cells, is crucial for blood vessel formation and cell clearance. Its abnormal expression in diseases like cancer suggests it
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- CD93 is a transmembrane glycoprotein with C-type lectin-like (CTLD) and EGF-like domains.
- It is primarily expressed in endothelial cells (ECs).
- CD93 plays roles in angiogenesis, cell adhesion, migration, and apoptotic cell clearance via ligands like MMRN2 and IGFBP7.
Purpose of the Study:
- To review the structure, function, and disease mechanisms of CD93.
- To highlight CD93's role in pathological conditions.
- To discuss CD93 as a potential therapeutic target.
Main Methods:
- Literature review of CD93 research.
- Analysis of CD93 expression in various diseases.
- Examination of CD93's functional domains and interactions.
Main Results:
- CD93 regulates key physiological processes in ECs.
- Aberrant CD93 expression is linked to inflammation, cardiovascular diseases, autoimmune disorders, and cancer.
- Overexpression in tumor vasculature correlates with poor prognosis.
Conclusions:
- CD93 is a significant regulator of endothelial cell function and a potential biomarker in disease.
- Targeting CD93 may improve tumor vascular function and immunotherapy efficacy.
- Further research is needed for clinical translation.
Abstract:
CD93 is a highly glycosylated transmembrane glycoprotein with key functional domains, including a C-type lectin-like domain (CTLD) and epidermal growth factor (EGF)-like domains. Primarily expressed in endothelial cells (ECs), CD93 regulates critical physiological processes such as angiogenesis, cell adhesion, migration, and apoptotic cell clearance through interactions with ligands like multimerin-2 (MMRN2) and insulin-like growth factor-binding protein 7 (IGFBP7). Aberrant CD93 expression has been observed in various pathological conditions, including inflammation, cardiovascular diseases, autoimmune disorders, and cancer. Notably, CD93 is overexpressed in tumor-associated blood vessels, which is associated with poor prognosis and advanced disease stages. Targeting the CD93 signaling pathway has the potential to improve tumor vascular function and enhance the efficacy of immunotherapy, making it a promising therapeutic target. This review summarizes the current understanding of CD93's structure, function, and disease mechanisms, providing a framework for further research and clinical translation in related fields.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
iPS Cell Differentiation

